Company: SHPH
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001493152-25-002253
Chunk: 242

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-15
Form: S-1
Chunk 242
---
2024, the Company informed the Investor in the Alto Convertible Note that the Company’s expected restatement of its consolidated financial statements for the years ended December 31, 2022 and 2023 constituted an event of default under the terms of the Alto Convertible Note. On August 6, 2024, the Company paid $ 600,000to the Investor, which funds will be held as collateral to the balance owed under the Alto Convertible Note, and received a waiver from the Investor related to the default.

Alliance Global Partners

On July 30, 2024, the Company
engaged A.G.P./Alliance Global Partners (“AGP”) to serve as exclusive underwriter, placement agent or advisor in
any public or private offering or financing (as defined, the “Offering”) of up to $10million.

| F-46 |

<div align='center'>Up to 1,464,268 Shares of Common Stock Issuable Upon Conversion of 14.5% Senior Secured Convertible Notes

Up to 329,461 Shares of Common Stock Issuable Upon Exercise of Warrants

SHUTTLE PHARMACEUTICALS HOLDINGS, INC.

PROSPECTUS

__, 2025</div>

<div align='center'>PART II</div>

INFORMATION NOT REQUIRED IN THE PROSPECTUS

| ITEM 
 13.  | OTHER                                 
 EXPENSES OF ISSUANCE AND DISTRIBUTION |

The following table sets forth the estimated costs and expenses payable by the registrant expected to be incurred in connection with the sale and distribution of the securities being registered hereby. All of such costs and expenses are estimates, except for the SEC registration fee and the Financial Industry Regulatory Authority (“FINRA”) filing fee.

| SEC Filing Fees              |     | $ |      - |
| FINRA Expenses               |     | $ |      - |
| Accounting Fees and Expenses |     | $ | 20,000 |
| Legal Fees and Expenses      |     | $ | 30,000 |
| Transfer Agent Fees          |     | $ |      - |
| Financial Printing Fees      |     | $ |      - |
| Miscellaneous                
 Fees and Expenses            |     | $ |      - |
| Total                        |     | $ | 50,000 |

All amounts are estimates other than the SEC and FINRA filing fees.

| ITEM 
 14.  | INDEMNIFICATION           
 OF DIRECTORS AND OFFICERS |

Section 145